Literature DB >> 22591503

Carbon dioxide laser: first-line therapy in vulvar inflammatory linear verrucous epidermal nevus.

Antonietta D'Antuono1, Riccardo Balestri, Stefania Zauli, Federico Bardazzi, Sara Bellavista, Nicoletta Banzola, Paola Sgubbi, Annalisa Patrizi.   

Abstract

Inflammatory linear verrucous epidermal nevus (ILVEN) is normally associated with the failure of topical and systemic treatments and with recurrences on interruption of therapy. Many physical approaches have been used, but they generally resulted in varying rates of recurrence and unacceptable scarring. We reported a case of ILVEN treated with a single session CO(2) laser treatment. In our experience, CO(2) laser was quick, easy, effective, and safe; we therefore believe that this approach should be considered as a first-line surgical option in the treatment of genital ILVEN, particularly in cases of mucosal involvement.
© 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2012        PMID: 22591503     DOI: 10.1111/j.1529-8019.2012.01429.x

Source DB:  PubMed          Journal:  Dermatol Ther        ISSN: 1396-0296            Impact factor:   2.851


  4 in total

Review 1.  Lasers for nevi: a review.

Authors:  Harleen Arora; Leyre Falto-Aizpurua; Anna Chacon; Robert D Griffith; Keyvan Nouri
Journal:  Lasers Med Sci       Date:  2014-12-16       Impact factor: 3.161

2.  Vulvar and perianal condyloma superimposed inflammatory linear verrucous epidermal nevus: a case report and review of the literature.

Authors:  Sümeyra Nergız Avcioğlu; Sündüz Özlem Altinkaya; Mert Küçük; Hasan Yüksel; Selda Demircan-Sezer; Gonca Uçar
Journal:  Case Rep Dermatol Med       Date:  2013-12-17

3.  Widely Spread Unilateral Inflammatory Linear Verrucous Epidermal Nevus (ILVEN).

Authors:  Kayo Tanita; Taku Fujimura; Yota Sato; Chunbing Lyu; Setsuya Aiba
Journal:  Case Rep Dermatol       Date:  2018-06-14

4.  Genital/Perigenital Inflammatory Linear Verrucous Epidermal Nevus: A Case Series.

Authors:  Debabrata Bandyopadhyay; Abanti Saha
Journal:  Indian J Dermatol       Date:  2015 Nov-Dec       Impact factor: 1.494

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.